EMIS is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules or nutritional supplements using its Eligen(R) Technology.These molecules and compounds could be currently available or in development. Such molecules are usually delivered by injection; in many cases, their benefits are limited due to poor bioavailability, slow on-set of action or variable absorption.
The Eligen(R) Technology can be applied to the oral route of administration as well as other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal.
Vitamin B12 is necessary for the formation and maturation of red blood cells and for the synthesis of DNA. It is also necessary for normal nerve function and assists in the body's immune system. B12 deficiency is a major health concern that can lead to anemia, fatigue, weakness, loss of appetite, neurological changes, confusion and dementia.
Unlike most vitamins, B12 is stored in the liver until it is needed by the body. Vitamin B12 is adequately absorbed in the bodies of healthy people, but many older people lose their natural ability to absorb the nutrient.
Younger individuals may also have difficulty absorbing B12 as a result of taking certain medications or chemotherapy. Those at highest risk for B12 deficiency include anyone over age 60, those with GI tract disorders such as Crohn's Disease, Irritable Bowel Syndrome or Celiac Disease, individuals who have had bypass surgery, those undergoing chronic therapy with absorption-altering drugs, alcoholics and vegetarians/vegans.It is estimated that between 30 and 40 million high-dose injections of B12 are given each year in the U.S. alone and that more than 250 million such injections are given worldwide.
** EMIS reported that it is engaged in ongoing discussions with a potential licensee for its high dose oral Eligen(R) B12 1000mcg as a Medical Food for individuals with B12 deficiency.
EMIS is evaluating other potential licensees as well as the possibility of marketing the product without a partner.
A recently completed clinical trial showed that high dose Eligen(R) B12 1000mcg can efficiently and quickly restore Vitamin B12 levels in deficient individuals compared to the current standard of care.More about EMIS at http://www.emisphere.com/
No comments:
Post a Comment